Ferring International Center S.A. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 46 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Ferring International Center S.A. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Ferring International Center S.A. - Product Pipeline Review - 2014', provides an overview of the Ferring International Center S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ferring International Center S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Ferring International Center S.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Ferring International Center S.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Ferring International Center S.A.'s pipeline products

Reasons to buy

- Evaluate Ferring International Center S.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Ferring International Center S.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Ferring International Center S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Ferring International Center S.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ferring International Center S.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Ferring International Center S.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ferring International Center S.A. Snapshot 5
Ferring International Center S.A. Overview 5
Key Information 5
Key Facts 5
Ferring International Center S.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Ferring International Center S.A. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
Ferring International Center S.A. - Pipeline Products Glance 15
Ferring International Center S.A. - Late Stage Pipeline Products 15
Phase III Products/Combination Treatment Modalities 15
Ferring International Center S.A. - Clinical Stage Pipeline Products 16
Phase II Products/Combination Treatment Modalities 16
Phase I Products/Combination Treatment Modalities 17
Ferring International Center S.A. - Early Stage Pipeline Products 18
Preclinical Products/Combination Treatment Modalities 18
Ferring International Center S.A. - Drug Profiles 19
degarelix 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
follitropin delta 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Testavan 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
barusiban 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
FE-202767 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
FE-992097 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
FE-999309 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
selepressin 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
FE-204205 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
FE-999301 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
FE-201874 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
FE-203799 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
FE-999310 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Ferring International Center S.A. - Pipeline Analysis 33
Ferring International Center S.A. - Pipeline Products by Target 33
Ferring International Center S.A. - Pipeline Products by Route of Administration 34
Ferring International Center S.A. - Pipeline Products by Molecule Type 35
Ferring International Center S.A. - Pipeline Products by Mechanism of Action 36
Ferring International Center S.A. - Recent Pipeline Updates 37
Ferring International Center S.A. - Dormant Projects 39
Ferring International Center S.A. - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 46
Disclaimer 46

List of Tables
Ferring International Center S.A., Key Information 5
Ferring International Center S.A., Key Facts 5
Ferring International Center S.A. - Pipeline by Indication, 2014 8
Ferring International Center S.A. - Pipeline by Stage of Development, 2014 9
Ferring International Center S.A. - Monotherapy Products in Pipeline, 2014 10
Ferring International Center S.A. - Partnered Products in Pipeline, 2014 11
Ferring International Center S.A. - Partnered Products/ Combination Treatment Modalities, 2014 12
Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2014 13
Ferring International Center S.A. - Out-Licensed Products/ Combination Treatment Modalities, 2014 14
Ferring International Center S.A. - Phase III, 2014 15
Ferring International Center S.A. - Phase II, 2014 16
Ferring International Center S.A. - Phase I, 2014 17
Ferring International Center S.A. - Preclinical, 2014 18
Ferring International Center S.A. - Pipeline by Target, 2014 33
Ferring International Center S.A. - Pipeline by Route of Administration, 2014 34
Ferring International Center S.A. - Pipeline by Molecule Type, 2014 35
Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2014 36
Ferring International Center S.A. - Recent Pipeline Updates, 2014 37
Ferring International Center S.A. - Dormant Developmental Projects,2014 39
Ferring International Center S.A., Other Locations 40
Ferring International Center S.A., Subsidiaries 41